M. Zell

发表

Rapid screening and characterization of drug metabolites using a new quadrupole-linear ion trap mass spectrometer.

G. Hopfgartner, C. Husser, M. Zell, 2003, Journal of mass spectrometry : JMS.

A double-tracer technique to characterize absorption, distribution, metabolism and excretion (ADME) of [14C]-basimglurant and absolute bioavailability after oral administration and concomitant intravenous microdose administration of [13C6]-labeled basimglurant in humans

T. Hartung, C. Funk, C. Husser, 2017, Xenobiotica; the fate of foreign compounds in biological systems.

High-Throughput Quantification of Drugs and Their Metabolites in Biosamples by LC-MS/MS and CE-MS/MS: Possibilities and Limitations

G. Hopfgartner, C. Husser, M. Zell, 2002, Therapeutic drug monitoring.

Quantitative profiling of prostaglandins as oxidative stress biomarkers in vitro and in vivo by negative ion online solid phase extraction - Liquid chromatography-tandem mass spectrometry.

B. Ernst, C. Husser, M. Zell, 2016, Analytical biochemistry.

Pharmacokinetics and metabolism of the dipeptidyl peptidase IV inhibitor carmegliptin in rats, dogs, and monkeys

C. Funk, M. Zell, O. Kuhlmann, 2010, Xenobiotica; the fate of foreign compounds in biological systems.

Pharmacokinetics and pharmacodynamics of Ro 44-3888 after single ascending oral doses of sibrafiban, an oral platelet aggregation inhibitor, in healthy male volunteers.

I. Mackie, S. Machin, M. Zell, 1999, British journal of clinical pharmacology.

Profiling of dalcetrapib metabolites in human plasma by accelerator mass spectrometry and investigation of the free phenothiol by derivatisation with methylacrylate

C. Husser, M. Zell, S. Schadt, 2018, Journal of pharmaceutical and biomedical analysis.

Experimental model for the investigation of kinetic and/or dynamic interactions between drugs and ethanol in humans.

M. Zell, D. Hartmann, W. Ziegler, 1988, Journal of pharmaceutical sciences.

Volume of distribution of theophylline in acute exacerbations of reversible airway disease. Effect of body weight.

M. Zell, J. Fischer, W. G. Troyer, 1985, Chest.

Low picogram determination of Ro 48-6791 and its major metabolite, Ro 48-6792, in plasma with column-switching microbore high-performance liquid chromatography coupled to ion spray tandem mass spectrometry.

G. Hopfgartner, C. Husser, M. Zell, 1997, Rapid communications in mass spectrometry : RCM.

Sensitive gas-liquid chromatographic method for the determination of oxiconazole in plasma.

M. Zell, U. Timm, L. Herzfeld, 1982, Journal of chromatography.

Identification of GalNAc-Conjugated Antisense Oligonucleotide Metabolites Using an Untargeted and Generic Approach Based on High Resolution Mass Spectrometry.

C. Husser, M. Zell, S. Schadt, 2017, Analytical chemistry.

Metabolism and mass balance of SGLT2 inhibitor tofogliflozin following oral administration to humans

C. Husser, M. Zell, O. Kuhlmann, 2014, Xenobiotica; the fate of foreign compounds in biological systems.

Integrated pharmacokinetics and pharmacodynamics of Ro 48-6791, a new benzodiazepine, in comparison with midazolam during first administration to healthy male subjects.

A. Cohen, M. Zell, J. V. van Gerven, 2003, British journal of clinical pharmacology.

Integrated pharmacokinetics and pharmacodynamics of Ro 48-8684, a new benzodiazepine, in comparison with midazolam during first administration to healthy male subjects.

J. Gerven, A. Cohen, M. Zell, 2003, British journal of clinical pharmacology.

Pharmacokinetic-pharmacodynamic modelling of the EEG effects of Ro 48-6791, a new short-acting benzodiazepine, in young and elderly subjects.

H. Schwilden, J. Schüttler, S. Albrecht, 1997, British journal of anaesthesia.

Accuracy of 11 methods for predicting theophylline dose.

M. Zell, K. Rodvold, F. Paloucek, 1986, Clinical pharmacy.

In Vivo Biotransformation of the Fusion Protein Tetranectin-Apolipoprotein A1 Analyzed by Ligand-Binding Mass Spectrometry Combined with Quantitation by ELISA.

C. Husser, M. Zell, S. Schadt, 2016, Analytical chemistry.

Column-switching high-performance liquid chromatography combined with ionspray tandem mass spectrometry for the simultaneous determination of the platelet inhibitor Ro 44-3888 and its pro-drug and precursor metabolite in plasma.

G. Hopfgartner, C. Husser, M. Zell, 1997, Journal of mass spectrometry : JMS.

Highly sensitive assay of benzodiazepine antagonist in plasma by capillary gas chromatography with nitrogen-selective detection.

M. Zell, U. Timm, 1986, Journal of chromatography.

Flumazenil kinetics in the elderly

M. Zell, W. Weber, G. Roncari, 2004, European Journal of Clinical Pharmacology.

Pharmacokinetics and Pharmacodynamics of Ro 41–3696, a Novel Nonbenzodiazepine Hypnotic

R. Gieschke, M. Zell, J. Dingemanse, 1995, Journal of clinical pharmacology.

Determination of dalcetrapib by liquid chromatography-tandem mass spectrometry.

K. Heinig, M. Zell, O. Kuhlmann, 2012, Journal of pharmaceutical and biomedical analysis.

The Application of Liquid Chromatography and Capillary Zone Electrophoresis Combined with Atmospheric Pressure Ionisation Mass Spectrometry for the Analysis of Pharmaceutical Compounds in Biological Fluids

B. Lausecker, G. Hopfgartner, C. Husser, 1999, CHIMIA.

Preformulation Approaches to Improve the Oral Bioavailability of Two Novel Piperidine Renin Inhibitors in Dog

T. Lavé, M. Zell, M. Schleimer, 2002, Arzneimittelforschung.

Determination of the benzodiazepine antagonist Ro 15-1788 in plasma by high-performance liquid chromatography with UV detection.

M. Zell, U. Timm, 1983, Arzneimittel-Forschung.